Skip to main content
. 2019 Oct 15;19:100473. doi: 10.1016/j.conctc.2019.100473

Table 2.

Summary of subject Mean (SD) for Polymorphonuclear (PMN) Leukocytes and dental plaque, gingival index scores at all examinations for subjects who completed the entire study.

Parameter Treatment Baseline Mean (S.D)a 1 Week Mean (S.D) 2 Week Mean (S.D)
PMN leukocytes (log10Count/ml) Test 5.474 (0.193) 5.247 (0.192) 5.082 (0.212)
Control 5.450 (0.214) 5.417 (0.214) 5.404 (0.221)
Gingival Index Test 1.47 (0.29) 1.150 (0.21) 0.96 (0.23)
Control 1.46 (0.25) 1.36 (0.25) 1.28 (0.24)
Plaque Index Test 2.64 (0.5) 1.964 (0.59) 1.75 (0.55)
Control 2.65 (0.47) 2.33 (0.44) 2.17 (0.44)
Gingival Severity Test 0.37 (0.18) 0.20 (0.15) 0.10 (0.13)
Control 0.38 (0.17) 0.32 (0.17) 0.28 (0.18)
Plaque Severity Test 0.42 (0.17) 0.22 (0.17) 0.19 (0.16)
Control 0.42 (0.17) 0.33 (0.16) 0.30 (0.16)
Gingival Interproximal Test 1.48 (0.28) 1.20 (0.18) 1.07 (0.17)
Control 1.47 (0.25) 1.36 (0.24) 1.29 (0.23)
Plaque Interproximal Test 2.68 (0.5) 2.01 (0.59) 1.80 (0.54)
Control 2.68 (0.5) 2.38 (0.43) 2.23 (0.45)
a

No statistically significant difference was indicated between the two treatment groups at baseline with respect to PMN leukocytes (log10Count/ml) samples (p = 0.576); gingival index (p = 0.952); plaque index (p = 0.773); gingival severity (p = 0.754); plaque severity (p = 0.916); gingival interproximal (p = 0.884); plaque interproximal (p = 0.939).